Patents by Inventor Nikolai Khodarev

Nikolai Khodarev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-tumor therapy
    Patent number: 10561708
    Abstract: Compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involving one or more inhibitors of the JAK/STAT pathway which renders the cancer chemosensitive and/or radiosensitive.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: February 18, 2020
    Assignee: The University of Chicago
    Inventors: Nikolai Khodarev, Ravi Sood, Bernard Roizman, Ralph R. Weichselbaum
  • Anti-tumor therapy
    Patent number: 10421971
    Abstract: Compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involving one or more genes the suppression of which renders the cancer chemosensitive and/or radiosensitive.
    Type: Grant
    Filed: October 24, 2014
    Date of Patent: September 24, 2019
    Inventors: Liufu Deng, Yang-xin Fu, Nikolai Khodarev, Ralph Weichselbaum
  • ANTI-TUMOR THERAPY
    Publication number: 20190071679
    Abstract: Panels, compositions, and methods for treating cancer in a subject in need thereof are disclosed involving one or more genes the suppression of which renders the cancer chemosensitive and/or radiosensitive.
    Type: Application
    Filed: November 2, 2018
    Publication date: March 7, 2019
    Inventors: Nikolai Khodarev, Ravi Sood, Bernard Roizman, Ralph Weichselbaum
  • ANTI-TUMOR THERAPY
    Publication number: 20180256678
    Abstract: Compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involving one or more inhibitors of the JAK/STAT pathway which renders the cancer chemosensitive and/or radiosensitive.
    Type: Application
    Filed: May 9, 2018
    Publication date: September 13, 2018
    Inventors: Nikolai Khodarev, Ravi Sood, Bernard Roizman, Ralph R. Weichselbaum
  • ANTI-TUMOR THERAPY
    Publication number: 20170298362
    Abstract: Panels, compositions, and methods for treating cancer in a subject in need thereof are disclosed involving one or more genes the suppression of which renders the cancer chemosensitive and/or radiosensitive.
    Type: Application
    Filed: June 29, 2017
    Publication date: October 19, 2017
    Inventors: Nikolai Khodarev, Ravi Sood, Bernard Roizman, Ralph Weichselbaum
  • Anti-tumor therapy
    Patent number: 9790504
    Abstract: Panels, compositions, and methods for treating cancer in a subject in need thereof are disclosed involving one or more genes the suppression of which renders the cancer chemosensitive and/or radiosensitive.
    Type: Grant
    Filed: May 21, 2014
    Date of Patent: October 17, 2017
    Assignee: The University of Chicago
    Inventors: Nikolai Khodarev, Ravi Sood, Bernard Roizman, Ralph R. Weichselbaum
  • ANTI-TUMOR THERAPY
    Publication number: 20160367627
    Abstract: Compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involving one or more inhibitors of the JAK/STAT pathway which renders the cancer chemosensitive and/or radiosensitive.
    Type: Application
    Filed: June 24, 2014
    Publication date: December 22, 2016
    Inventors: Nikolai Khodarev, Ravi Sood, Bernard Roizman, Ralph R. Weichselbaum
  • ANTI-TUMOR THERAPY
    Publication number: 20160333355
    Abstract: Compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involving one or more genes the suppression of which renders the cancer chemosensitive and/or radiosensitive.
    Type: Application
    Filed: October 24, 2014
    Publication date: November 17, 2016
    Applicant: THE UNIVERSITY OF CHICAGO
    Inventors: Liufu Deng, Yang-xin Fu, Nikolai Khodarev, Ralph Weichselbaum
  • ANTI-TUMOR THERAPY
    Publication number: 20160222387
    Abstract: Panels, compositions, and methods for treating cancer in a subject in need thereof are disclosed involving one or more genes the suppression of which renders the cancer chemosensitive and/or radiosensitive.
    Type: Application
    Filed: May 21, 2014
    Publication date: August 4, 2016
    Applicant: THE UNIVERSITY OF CHICAGO
    Inventors: Nikolai Khodarev, Ravi Sood, Bernard Roizman, Ralph R. Weichselbaum
  • Prognosis and Therapy Predictive Markers and Methods of Use
    Publication number: 20110200998
    Abstract: Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.
    Type: Application
    Filed: February 8, 2011
    Publication date: August 18, 2011
    Applicant: THE UNIVERSITY OF CHICAGO
    Inventors: Ralph Weichselbaum, Bernard Roizman, Andy Minn, Nikolai Khodarev, Edwardine Labay
  • Prognosis and therapy predictive markers and methods of use
    Patent number: 7892740
    Abstract: Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.
    Type: Grant
    Filed: January 19, 2007
    Date of Patent: February 22, 2011
    Assignee: The University of Chicago
    Inventors: Ralph Weichselbaum, Bernard Roizman, Andy Minn, Nikolai Khodarev, Edwardine Labay
  • Methods and kits for monitoring Barrett's metaplasia
    Patent number: 7537894
    Abstract: Disclosed are methods and kits for assessing risk of progression of Barrett's esophagus to adenocarcinoma.
    Type: Grant
    Filed: March 2, 2006
    Date of Patent: May 26, 2009
    Assignee: The University of Chicago
    Inventors: Ralph Weichselbaum, Nikolai Khodarev, Eric Kimchi, Mitchell Posner
  • Prognosis and Therapy Predictive Markers and Methods of Use
    Publication number: 20090011439
    Abstract: Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.
    Type: Application
    Filed: January 19, 2007
    Publication date: January 8, 2009
    Inventors: Ralph Weichselbaum, Bernard Roizman, Andy Minn, Nikolai Khodarev, Edwardine Labay
  • Methods and kits for monitoring Barrett's metaplasia
    Publication number: 20060199210
    Abstract: Disclosed are methods and kits for assessing risk of progression of Barrett's esophagus to adenocarcinoma.
    Type: Application
    Filed: March 2, 2006
    Publication date: September 7, 2006
    Inventors: Ralph Weichselbaum, Nikolai Khodarev, Eric Kimchi, Mitchell Posner
  • Methods and kits for use in selecting approaches to treating cancer
    Publication number: 20050048491
    Abstract: This invention provides methods and kits for use in selecting approaches to treating cancer, as well as methods for identifying genes that can be used in such methods and kits.
    Type: Application
    Filed: October 9, 2002
    Publication date: March 3, 2005
    Inventors: Ralph Weichselbaum, Bernard Roizman, Nikolai Khodarev, Nalin Gupta